- by
- 01 30, 2025
Loading
ON OCTOBER 19th, , an American newspaper, reported that surgeons in New York had successfully transplanted a pig kidney into a human subject. The organ was successfully attached for three days in an experimental procedure on a brain-dead patient. It was the culmination of years of work; scientists have dreamed of xenotransplantation, in which organs from animals are put into humans, for decades. The successful transplant shows both how far science has come in this process, and how far it still has to go.In 2014, a firm called Synthetic Genomics in La Jolla, California, began work on a unique and radical project. The idea was to make a raft of genetic changes to pigs so that their organs would be more suitable for transplantation into humans without rejection. The purpose was to address the growing shortage of organs for transplantation. Synthetic Genomics partnered with another biotech firm, United Therapeutics Corporation, based in Silver Spring, Maryland. United Therapeutics reckons that in America alone, 1m people each year have end-stage organ disease and may need a heart, kidney, or lung transplant.